Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021

SELL
$63.47 - $69.35 $308,718 - $337,318
-4,864 Closed
0 $0
Q1 2021

Apr 19, 2021

BUY
$60.0 - $68.46 $63,840 - $72,841
1,064 Added 28.0%
4,864 $314,000
Q4 2020

Feb 08, 2021

BUY
$56.65 - $64.55 $19,997 - $22,786
353 Added 10.24%
3,800 $221,000
Q3 2020

Nov 02, 2020

SELL
$62.1 - $78.08 $2,980 - $3,747
-48 Reduced 1.37%
3,447 $217,000
Q2 2020

Aug 10, 2020

BUY
$72.34 - $84.0 $2,676 - $3,108
37 Added 1.07%
3,495 $268,000
Q1 2020

May 11, 2020

SELL
$62.63 - $80.22 $15,156 - $19,413
-242 Reduced 6.54%
3,458 $258,000
Q4 2019

Feb 07, 2020

SELL
$61.62 - $67.78 $29,392 - $32,331
-477 Reduced 11.42%
3,700 $240,000
Q3 2019

Nov 06, 2019

SELL
$62.51 - $69.0 $51,195 - $56,511
-819 Reduced 16.39%
4,177 $264,000
Q2 2019

Aug 06, 2019

BUY
$61.87 - $69.38 $17,385 - $19,495
281 Added 5.96%
4,996 $337,000
Q1 2019

May 08, 2019

SELL
$62.53 - $70.05 $72,597 - $81,328
-1,161 Reduced 19.76%
4,715 $306,000
Q4 2018

Feb 07, 2019

SELL
$60.54 - $79.0 $278,484 - $363,400
-4,600 Reduced 43.91%
5,876 $367,000
Q3 2018

Nov 05, 2018

SELL
$71.28 - $78.92 $174,921 - $193,669
-2,454 Reduced 18.98%
10,476 $808,000
Q2 2018

Aug 02, 2018

SELL
$64.88 - $75.68 $48,854 - $56,987
-753 Reduced 5.5%
12,930 $915,000
Q1 2018

Apr 26, 2018

SELL
$72.84 - $88.8 $88,136 - $107,448
-1,210 Reduced 8.12%
13,683 $0
Q4 2017

Feb 01, 2018

BUY
$71.15 - $83.52 $900,260 - $1.06 Million
12,653 Added 564.87%
14,893 $1.07 Million
Q4 2017

Jan 29, 2018

BUY
$71.15 - $83.52 $159,376 - $187,084
2,240
2,240 $1.16 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Ifg Advisory, LLC Portfolio

Follow Ifg Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisory, LLC with notifications on news.